Priya Dayananth

Statistics

Publications

Citations

8.5K

H-Index

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Myriad Genetics

University of Utah

Priya Dayananth is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and molecular oncology.

Publications per year

1994–2022

Publications

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene <i>BRCA1</i>

Yoshio Miki, Jeffrey Swensen, Donna Shattuck-Eidens et al. · Science · 1994 · 6.1K citations

Life Sciences, Genetics, Molecular Genetics +17

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 685 citations · Full text

Medicine, Oncology, Pharmacology +17

A candidate prostate cancer susceptibility gene at chromosome 17p

Sean V. Tavtigian, Jacques Simard, David H.F. Teng et al. · Nature Genetics · 2001 · 555 citations

Medicine, Genetics, Molecular Genetics +11

Complex structure and regulation of the P16 (MTS1) locus.

Steven Stone, Ping Jiang, Priya Dayananth et al. · PubMed · 1995 · 396 citations

Life Sciences, Molecular Biology, Molecular Genetics +11

Characterization of a carboxy-terminal BRCA1 interacting protein

Alexander Wong, Patricia A. Ormonde, Ralph Pero et al. · Oncogene · 1998 · 165 citations

Life Sciences, Biochemistry, Molecular Biology +8

1–5 of 16